PBE Holdings

34 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.

Top 25 Holdings

#HoldingWeightShares (as reported)Value (as reported)
1Illumina Inc6.19%95,399$25.5M
2Natera Inc6.11%63,745$25.2M
3Biogen Inc5.23%97,223$21.6M
4Gilead Sciences Inc5.13%144,274$21.2M
5Amgen Inc4.86%48,534$20.0M
6Vertex Pharmaceuticals Inc4.75%38,824$19.6M
7Royalty Pharma PLC4.75%345,798$19.6M
8Regeneron Pharmaceuticals Inc4.63%25,749$19.1M
9Moderna Inc3.51%73,715$14.5M
10Novavax Inc3.37%1,240,199$13.9M
11United Therapeutics Corp2.98%22,579$12.3M
12Exelixis Inc2.92%206,408$12.1M
13QIAGEN NV2.91%268,212$12.0M
14Halozyme Therapeutics Inc2.87%107,094$11.9M
15Veracyte Inc2.78%265,837$11.5M
16TG Therapeutics Inc2.71%211,250$11.2M
17Vericel Corp2.67%270,881$11.0M
18Protagonist Therapeutics Inc2.65%77,744$11.0M
19Neurocrine Biosciences Inc2.65%76,336$11.0M
20Sarepta Therapeutics Inc2.62%618,788$10.8M
21Repligen Corp2.61%64,437$10.8M
22Legend Biotech Corp2.55%549,646$10.5M
23Incyte Corp2.48%90,252$10.2M
24Ardelyx Inc2.45%3,097,216$10.1M
25PTC Therapeutics Inc2.44%159,351$10.1M

Sector Weights

  • Cash & Others: 0.00%
  • Financial Services: 0.08%
  • Healthcare: 99.92%

Country Weights

  • United States: 97.02%
  • Netherlands: 2.90%
  • Other: 0.08%

Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.